Cellular mechanisms of lipodystrophy induction by HIV protease inhibitors

Author： Zhou Huiping Pandak William M Hylemon Phillip B

ISSN： 1746-0875

Source： Future Lipidology, Vol.1, Iss.2, 2006-04, pp. : 163-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ritonavir-boosted protease inhibitors in HIV therapy

By Hull Mark W. Montaner Julio S. G.

Annals of Medicine, Vol. 43, Iss. 5, 2011-08 ,pp. : 375-388

Informa Healthcare

Access to resources Recommend Favorite

New HIV protease inhibitors for drug-resistant viruses

By Rusconi Stefano Viganòò Ottavia

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 79-88

Future Medicine

Access to resources Recommend Favorite

Effects of NO‐Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 5, 2015-11 ,pp. : 306-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms

By Olivier M. Badaró R. Medrano F. J. Moreno J.

Annals of Tropical Medicine and Parasitology, Vol. 97, Iss. 1, 2003-10 ,pp. : 79-98

Maney Publishing

Access to resources Recommend Favorite

Serum concentrations of protease inhibitors as predictors of HIV-related clinical events in patients on antiretroviral therapy

By Ormaasen Vidar Sandvik Leiv Rudberg Nina Bruun Johan

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 8, 2006-08 ,pp. : 650-653

Informa Healthcare

Access to resources Recommend Favorite